MDL 2067: In Re: Celexa and Lexapro Marketing and Sales Practices Litigation
LEAD CASE NUMBER 1:09-md-2067
Plaintiffs in these actions allege that Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. engaged in false and misleading promotion of Celexa and Lexapro for pediatric or adolescent use and sought to induce physicians and others to prescribe Celexa or Lexapro by providing them with various forms of illegal remuneration. The Plaintiffs further allege that this conduct caused them economic harm. These cases have been assigned to Judge Nathaniel M Gorton.
To view the docket entries, they can click here.
To view the Liason Counsel information, they can click here.
To view the Opinions, they can click here.